ALSEN.PA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 16:33):

Stats
Dagens volum	18 759.00
Gjennomsnittsvolum	121 206
Markedsverdi	213.07M
EPS	€0 ( 2024-03-14 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-4.18
ATR14	€0.0150 (2.11%)

Sensorion SA Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Sensorion SA Økonomi

Annual	2023
Omsetning:	€4.74M
Bruttogevinst:	€3.79M (79.86 %)
EPS:	€-0.170

FY	2023
Omsetning:	€4.74M
Bruttogevinst:	€3.79M (79.86 %)
EPS:	€-0.170

FY	2022
Omsetning:	€4.93M
Bruttogevinst:	€4.16M (84.38 %)
EPS:	€-0.290

FY	2021
Omsetning:	€3.34M
Bruttogevinst:	€0.00 (0.00 %)
EPS:	€-0.190

Financial Reports:

No articles found.

Sensorion SA

Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.